Huangqin-tang ameliorates dextran sodium sulphate-induced colitis by regulating intestinal epithelial cell homeostasis, inflammation and immune response

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zou, Ying ^a   Lin, Jiantao ^a   Li, Wenyang ^a   Wu, Zhuguo ^a   He, Zhiwei ^a   Huang, Guoliang ^a   Wang, Jian ^a   Ye, Caiguo ^a   Cheng, Xiaoyan ^a   Ding, Congcong ^a   Zheng, Xuebao ^b   Chi, Honggang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; DEXTRAN SULFATE; HERBACEOUS AGENT; HUANGQIN-TANG; IMMUNOLOGIC FACTOR;

ANIMAL; C57BL MOUSE; COLITIS; CYTOCHEMISTRY; DISEASE MODEL; DRUG EFFECT; EPITHELIUM CELL; FEMALE; HOMEOSTASIS; INTESTINE MUCOSA; MOUSE; PATHOLOGY; PHYSIOLOGY; RAW 264.7 CELL LINE; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; EPITHELIAL CELLS; FEMALE; HISTOCYTOCHEMISTRY; HOMEOSTASIS; IMMUNOLOGIC FACTORS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; RAW 264.7 CELLS; SIGNAL TRANSDUCTION;

EID: 85006427602     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39299     Document Type: Article

References (47)

1. Kaser, A., Zeissig, S., Blumberg, R. S. Inflammatory bowel disease. Annu Rev Immunol 28, 573-621 (2010).
2. Maloy, K. J., Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306 (2011).
3. Cho, J. H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8, 458-66 (2008).
4. Fries, W., Belvedere, A., Vetrano, S. Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions. Curr Drug Targets 14, 1460-70 (2013).
5. Strober, W., Fuss, I. J., Blumberg, R. S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20, 495-549 (2002).
6. Ordas, I., Eckmann, L., Talamini, M., Baumgart, D. C., Sandborn, W. J. Ulcerative colitis. Lancet 380, 1606-19 (2012).
7. Baumgart, D. C., Sandborn, W. J. Crohn's disease. Lancet 380, 1590-605 (2012).
8. Zhao, J., Jiang, P., Zhang, W. Molecular networks for the study of TCM pharmacology. Brief Bioinform 11, 417-30 (2010).
9. Huang, L., Lv, Q., Liu, F., Shi, T., Wen, C. A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Shengma-bie-jia-tang Acting on Systemic Lupus Erythematosus by Multi-Level Data Integration. Sci Rep 5, 16401 (2015).
10. Liu, S. H., Cheng, Y. C. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol 140, 614-23 (2012).
11. Chen, P., et al. Anti-inflammatory effects of Huangqin tang extract in mice on ulcerative colitis. J Ethnopharmacol 162, 207-14 (2015).
12. Zou, Y., et al. Huangqin-Tang Ameliorates TNBS-Induced Colitis by Regulating Effector and Regulatory CD4(+ ) T Cells. Biomed Res Int 2015, 102021 (2015).
13. Okayasu, I., et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702 (1990).
14. Ahmad, R., et al. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis. Mucosal Immunol 7, 1340-53 (2014).
15. Dai, S. X., Zou, Y., Feng, Y. L., Liu, H. B., Zheng, X. B. Baicalin down-regulates the expression of macrophage migration inhibitory factor (MIF) effectively for rats with ulcerative colitis. Phytother Res 26, 498-504 (2012).
16. Neurath, M. F. Cytokines in inflammatory bowel disease. Nat Rev Immunol 14, 329-42 (2014).
17. Marrero, J. A., Matkowskyj, K. A., Yung, K., Hecht, G., Benya, R. V. Dextran sulfate sodium-induced murine colitis activates NFkappaB and increases galanin-1 receptor expression. Am J Physiol Gastrointest Liver Physiol 278, G797-804 (2000).
18. Schreiber, S., Nikolaus, S., Hampe, J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42, 477-84 (1998).
19. Rogler, G., et al. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115, 357-69 (1998).
20. Schiering, C., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-8 (2014).
21. Boden, E. K., Snapper, S. B. Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 24, 733-41 (2008).
22. Boehm, F., et al. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol 12, 97 (2012).
23. Xue, X., et al. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology 145, 831-41 (2013).
24. Dai, C., et al. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kappaB pathway in rat model of DSSinduced colitis. Mol Cell Biochem 374, 1-11 (2013).
25. Solomon, L., et al. The dextran sulphate sodium (DSS) model of colitis: an overview. Comparative Clinical Pathology 19, 235-239 (2010).
26. Elson, C. O., et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206, 260-76 (2005).
27. Lorenz, R. G., McCracken, V. J., Elson, C. O. Animal models of intestinal inflammation: ineffective communication between coalition members. Springer Semin Immunopathol 27, 233-47 (2005).
28. Di Sabatino, A., et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum 46, 1498-507 (2003).
29. Hagiwara, C., Tanaka, M., Kudo, H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol 17, 758-64 (2002).
30. Iwamoto, M., Koji, T., Makiyama, K., Kobayashi, N., Nakane, P. K. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 180, 152-9 (1996).
31. Frey, M. R., Edelblum, K. L., Mullane, M. T., Liang, D., Polk, D. B. The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology 136, 217-26 (2009).
32. Nenci, A., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-61 (2007).
33. Zhao, H., et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 12, 57 (2012).
34. Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9, 799-809 (2009).
35. Perse, M., Cerar, A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012, 718617 (2012).
36. Wirtz, S., Neufert, C., Weigmann, B., Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2, 541-6 (2007).
37. Savari, S., Vinnakota, K., Zhang, Y., Sjolander, A. Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer. World J Gastroenterol 20, 968-77 (2014).
38. Vignali, D. A., Collison, L. W., Workman, C. J. How regulatory T cells work. Nat Rev Immunol 8, 523-32 (2008).
39. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995-1004 (1999).
40. Liu, Z., Li, N., Neu, J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 94, 386-93 (2005).
41. Zhang, Y., Dube, P. E., Washington, M. K., Yan, F., Polk, D. B. ErbB2 and ErbB3 regulate recovery from dextran sulfate sodiuminduced colitis by promoting mouse colon epithelial cell survival. Lab Invest 92, 437-50 (2012).
42. Neufert, C., Becker, C., Neurath, M. F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2, 1998-2004 (2007).
43. Siegmund, B., Lehr, H. A., Fantuzzi, G., Dinarello, C. A. IL-1 beta-converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci USA 98, 13249-54 (2001).
44. Maeda, S., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307, 734-8 (2005).
45. Bell, C. J., Gall, D. G., Wallace, J. L. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268, G622-30 (1995).
46. Qiu, W., et al. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest 121, 1722-32 (2011).
47. Okazawa, A., et al. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement. Am J Gastroenterol 97, 3108-17 (2002).